BG
DICE

Bellevue Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bellevue Group’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,200
Closed -$846K – 166
2023
Q2 		$846K Buy
+18,200
New +$629K 0.01% 132

Bellevue Group's DICE Position: Q3 2023 in Review

Bellevue Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 18,200 shares — an estimated $846K sold.

Bellevue Group first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $846K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Bellevue Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bellevue Group sold 18,200 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $846K.
  • Bellevue Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Bellevue Group's DICE Therapeutics, Inc. Common Stock position peaked at $846K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bellevue Group's 13F filing for Q3 2023, filed 14 Nov 2023.